RenovoRx (RNXT) Profit After Tax (2020 - 2026)

RenovoRx has reported Profit After Tax for 7 years, with the latest figure at -$3.5 million in Q1 2026.

• Quarterly Profit After Tax fell 45.5% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.3 million (down 21.05% YoY) and the FY2025 annual result came in at -$11.2 million, down 26.71% from the prior year.
• Profit After Tax fell to -$3.5 million in Q1 2026 per RNXT's latest filing, from -$3.0 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$1.1 million in Q1 2024 and troughed at -$3.5 million in Q1 2026.
• A 5-year average of -$2.6 million and a median of -$2.6 million in 2022 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2022 and 2024: Profit After Tax sank 161.59% in 2022, then soared 66.96% in 2024.
• Over 5 years, Profit After Tax stood at -$2.2 million in 2022, then slumped by 49.68% to -$3.2 million in 2023, then rose by 10.81% to -$2.9 million in 2024, then dropped by 3.13% to -$3.0 million in 2025, then dropped by 18.63% to -$3.5 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$3.5 million, -$3.0 million, and -$2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.